SGLT2 inhibitor is kidney protective, even if eGFR <30
This video was recorded in response to a recent publication in CJASN by George Bakris and colleagues.
George L. Bakris, Professor of Medicine and Director of Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, IL, USA.
This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: